MSD has opened a $1bn facility in Durham located in the US state of North Carolina, to increase vaccine manufacturing ...

The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.

Lundbeck has gained ODD from Japan’s Ministry of Health, Labor and Welfare (MHLW) for amlenetug to treat multiple system ...

Kenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its investigational obesity drug, VK2735, as the biotech positions itself to ...

AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

Vaccinex went public in 2018, raising around $40m to advance its pipeline of neurodegenerative disease therapies. The initial ...

The EC has approved BMS Opdivo in combination with Yervoy as a first-line treatment for adults with unresectable or advanced ...

The offer represents a 3.6% increase from the initial offer in January 2025, from 62.5 pence per share to 64.75 pence per ...

A recent study published in Diabetologia has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a ...

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

Roche has announced the launch of the Roche Genentech Innovation Center Boston, which will serve as the company’s CVRM hub.